XML 17 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Apr. 28, 2018
Apr. 29, 2017
Apr. 30, 2016
Sales $ 3,662,280 $ 3,894,558 $ 4,163,844
Cost of sales and occupancy 2,551,077 2,682,356 2,836,547
Gross profit 1,111,203 1,212,202 1,327,297
Selling and administrative expenses 999,109 1,040,007 1,176,778
Depreciation and amortization 106,340 117,887 135,863
Goodwill impairment 133,612 [1] 0 0
Operating income (loss) (127,858) 54,308 14,656
Interest expense, net and amortization of deferred financing fees 9,837 7,509 8,770
Income (loss) before income taxes (137,695) 46,799 5,886
Income tax provision (benefit) (12,215) 24,776 (8,814)
Net income (loss) from continuing operations (125,480) 22,023 14,700
Net loss from discontinued operations     (39,146)
Net income (loss) $ (125,480) $ 22,023 $ (24,446)
Basic income (loss) per common share:      
Income (loss) from continuing operations $ (1.73) $ 0.30 $ 0.05
Loss from discontinued operations     (0.54)
Basic income (loss) per common share (1.73) 0.30 (0.49)
Diluted income (loss) per common share:      
Income (loss) from continuing operations (1.73) 0.30 0.05
Loss from discontinued operations     (0.54)
Diluted income (loss) per common share $ (1.73) $ 0.30 $ (0.49)
Weighted average common shares outstanding:      
Basic 72,588 72,188 72,410
Diluted 72,588 72,328 72,542
Dividends declared per common share $ 0.60 $ 0.60 $ 0.60
[1] See Note 1 for discussion on goodwill impairment testing.